Lipoprotein (a) in children with hypercholesterolemia as a marker of familiar history of cardiovascular risk;Lipoprotein (a) en ninos con hipercolesterolemia, como marcador de antecedentes familiares de riesgo cardiovascular

Anales Espanoles de Pediatria

Volumn 45, Issue 1, 1996, Pages 53-56

  Bayle, M Sánchez ^a   Mínguez, J Baeza ^a   Dupla, S Vila ^a   Quemada, C Ruiz Jarabo ^a   Antón, J Asensio ^a   Arnaiz, P ^a   Martin F ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

cardiovascular risk factor; familiar antecedents; hypercholesterolemia; lipoprotein (a)

Indexed keywords

LIPOPROTEIN; MARKER;

ADOLESCENT; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CONTROLLED STUDY; FAMILIAL DISEASE; FAMILY HISTORY; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; MAJOR CLINICAL STUDY; RISK ASSESSMENT;

EID: 9444269310     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Martínez Triguero ML, Vega García L, Mora Herranz A, Andreu Miquel L, Molina Andreu E. Lipoproteína (a). Química Clínica 1993;12:414-421.
2. Labeur C, De Bacquer D, De Backer G, Vincke J, Muyldermans L, Vanderkerckhove Y. Plasma lipoprotein (a) values and severity of coronary artery disease in large population of patients undergoing coronary angiography. Clin Chem 1992;38:2261-2266.
3. Del Río A. Lipoproteína (a). Med Clin (Barc) 1991;97:453-455.
4. Kostner GM, Czinner A, Pfeiffer KH, Bihari-Varga M. Lipoprotein (a) concentrations as risk indicators for atherosclerosis. Arch Dis Child 1991;66:1054-1056.
5. Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G. Lipoprotein (a) is an independent risk factor for myocardial infarction of a young age. Clin Chem 1990;36:20-23.
6. Vella JC, Jover E. Relation of lipoprotein (a) in 11 to 19 year-old-adolescents to parental cardiovascular heart disease. Clin Chem 1993;39:477-480.
7. Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS: Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Circulation 1991;84:160-167.
8. Wilcken DEL. Li Wang X, Greenwood J, Lynch J. Lipoprotein (a) and A-1 in children and coronary vascular events in their grandparents. J Pediatr 1993;123:519-526.
9. Siedel J, Schulumberger H, Klose S, Ziegenj-Horn J, Wahlefeld AW. Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Biochem 1981;19:838-839.
10. Fletcher MJ. Standarization of triglyceride methodology. Ann Clin Lab Sci 1972;2:389-392.
11. 2. Clin Chem 1983;29:2026-2030.
12. Friedewald WT, Levu RI, Fredickson DS. Estimation of the concentration of LDL-cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-507.
13. Labeur C, Michiels G, Borg J, Usher D, Rosseneu M. Lipoprotein (a) quantified by an enzyme-linked inmunoabsorbent assay with monoclonal antibodies. Clin Chem 1989;35:1380-1384.
14. Kwiterovitch PO Jr, Friedrickson DS, Levy RI. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest 1974;53:1237-1249.
15. Grupo Cooperative Español para el Estudio de los Factores de Riesgo Cardiovascular en la Infancia y Adolescencia. Factores de riesgo cardiovascular en la infancia y adolescencia. Estudio Ricardin II: Valores de referencia. An Esp Pediatr 1995;43:11-17.
16. Rosengren A, Wihelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein Lp(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J 1990;301:1248-1251.
17. Mezdour H, Parra HJ, Aguie-Aguie G, Fruchart JC. La lipoproteine (a). Un marqueur additionel de l'atherosclerose. Ann Biol Clin 1990;48:139-153.
18. Gutiérrez Fuentes JA, Gutiérrez Yago JJ, Díez Monedero E, Alvarez Berceruelo J, Zamorano Curiel P, Tejerina Abanades L. Lipoproteína (a): factor de riesgo para la aterosclerosis. Med Clin (Barc) 1989;93:565-567.
19. Farrer M, Game FI, Albers CJ, Neil HAW, Winocour PH, Laker MF, Adams PC, Alberti KGMM. Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease. Br Med J 1993;307:832-836.
20. Shepherd J. Importance and interaction of genetic and environmental factors in development of atherosclerosis. En: Vuylsteek H, Hallen M (Eds). Epidemiology. IOS Press, Brusell, 1994.
21. Hiraga T, Okubo M, Kobayashi T, Nakanishi K, Sugimoto T, Murase T. Serum lipoprotein (a) levels differ in different phenotypes of primary hyperlipoproteinemia. Metabolism 1993;42:1327-1330.
22. Imbew AD, Durrington PN. Lipoprotein (a): Structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 1990;85:1-14.
23. Ritter MM, Geiss HC, Ritcher WO, Schwandt P. Lipoprotein (a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia. Metabolism 1994;43:572-578.
24. Boyer H, de Gennes JL, Truffert J, Chatellier G, Dairou F, Bruckert E. Lp(a) levels in different types of dyslipidemia in the French population. Atherosclerosis 1990;85:61-69.